Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Northwestern University
mi
from
Chicago, IL
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Indiana University
mi
from
Indianapolis, IN
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Iowa
mi
from
Iowa City, IA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Iowa
mi
from
Iowa City, IA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Massachusetts General Hospital
mi
from
Charlestown, MA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Massachusetts General Hospital
mi
from
Charlestown, MA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
St. Mary's Health Care
mi
from
Grand Rapids, MI
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
St. Mary's Health Care
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Neurology Associates PC
mi
from
Lincoln, NE
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Neurology Associates PC
mi
from
Lincoln, NE
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Nevada School of Medicine
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Columbia University
mi
from
New York, NY
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Research Foundation of State University of New York
mi
from
Syracuse, NY
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Research Foundation of State University of New York
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Wake Forest University
mi
from
Winston-Salem, NC
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Ohio State University
mi
from
Columbus, OH
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Providence ALS Center
mi
from
Portland, OR
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Providence ALS Center
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
ALS Center at Penn
mi
from
Philadelphia, PA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
ALS Center at Penn
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Texas Neurology, PA
mi
from
Dallas, TX
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Texas Neurology, PA
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Methodist Neurological Institute
mi
from
Houston, TX
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Utah
mi
from
Salt Lake City, UT
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
University of Virginia Health System
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Univ of Washington
mi
from
Seattle, WA
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated:  12/13/2017
Prince of Wales Hospital
mi
from
Randwick,
Phase 3 Extension Study of Dexpramipexole in ALS
An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis
Status: Enrolling
Updated: 12/13/2017
Prince of Wales Hospital
mi
from
Randwick,
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Clinical Trials Incorporated
mi
from
Little Rock, AR
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Clinical Trials Incorporated
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Denver Health and Hospital Authority
mi
from
Denver, CO
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Denver Health and Hospital Authority
mi
from
Denver, CO
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
University of South Florida
mi
from
Tampa, FL
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Central DuPage Hospital
mi
from
Winfield, IL
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Central DuPage Hospital
mi
from
Winfield, IL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Via Christi Epilepsy Center
mi
from
Wichita, KA
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Via Christi Epilepsy Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Leonard J. Chabert Medical Center
mi
from
Houma, LA
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Leonard J. Chabert Medical Center
mi
from
Houma, LA
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Louisiana Research Associates, Inc.
mi
from
New Orleans, LA
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Mid-Atlantic Epilepsy and Sleep Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
The Comprehensive Epilepsy Care Center For Children and Adults
mi
from
Chesterfield, MO
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
The Comprehensive Epilepsy Care Center For Children and Adults
mi
from
Chesterfield, MO
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Montefiore Medicical Center
mi
from
Bronx, NY
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Montefiore Medicical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Langone Medical Center NYU Comprehensive Epilepsy Center
mi
from
New York, NY
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Langone Medical Center NYU Comprehensive Epilepsy Center
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Columbia University Medical Center: Dept of Neurology
mi
from
New York, NY
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Columbia University Medical Center: Dept of Neurology
mi
from
New York, NY
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
University of Rochester
mi
from
Rochester, NY
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated:  12/14/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy
Open-Label Study to Assess the Safety and Tolerability of Intravenous Carbamazepine as Short-Term Replacement of Oral Carbamazepine in Adult Patients With Epilepsy
Status: Enrolling
Updated: 12/14/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials